What’s New in Celiac Disease News? Chugai Pharmaceutical Publishes Non-Clinical Research Results on DONQ52 for Celiac Disease
Chugai Pharmaceutical Co., Ltd. recently published encouraging results from a non-clinical study on DONQ52, an experimental medication for celiac disease. The findings show its potential to block the immune response to gluten in celiac disease without affecting the rest of the immune system.
Continue Reading